Table of Contents
ISRN Oncology
Volume 2011, Article ID 645450, 10 pages
http://dx.doi.org/10.5402/2011/645450
Clinical Study

Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis

1Third Department of Surgery, SB Okmeydanı Training and Research Hospital, Istanbul, Turkey
2Fifth Department of Surgery, SB Okmeydanı Training and Research Hospital, Istanbul, Turkey
3Department of Surgery, Bayındır Levent Hospital, Istanbul, Turkey

Received 21 June 2011; Accepted 17 July 2011

Academic Editors: M. Emoto, A. M. Garcia-Lora, and M. R. Pfeffer

Copyright © 2011 Nüvit Duraker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Nemoto, J. Vana, and R. N. Bedwani, “Management and survival of female breast cancer: results of a national survey by the American college of surgeons,” Cancer, vol. 45, no. 12, pp. 2917–2924, 1980. View at Google Scholar · View at Scopus
  2. B. Fisher, M. Bauer, and D. L. Wickerham, “Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update,” Cancer, vol. 52, no. 9, pp. 1551–1557, 1983. View at Google Scholar · View at Scopus
  3. S. B. Edge, D. R. Byrd, C. C. Compton et al., AJCC Cancer Staging Handbook, Springer, New York, NY, USA, 7th edition, 2010.
  4. M. A. Kutiyanawala, M. Sayed, A. Stotter, R. Windle, and D. Rew, “Staging the axilla in breast cancer: an audit of lymph-node retrieval in one U.K. regional centre,” European Journal of Surgical Oncology, vol. 24, no. 4, pp. 280–282, 1998. View at Google Scholar · View at Scopus
  5. R. V. Iyer, A. Hanlon, B. Fowble et al., “Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 5, pp. 1177–1183, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Schaapveld, R. Otter, E. G. E. De Vries et al., “Variability in axillary lymph node dissection for breast cancer,” Journal of Surgical Oncology, vol. 87, no. 1, pp. 4–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Fortin, A. Dagnault, L. Blondeau, T. T. T. Vu, and M. Larochelle, “The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 65, no. 1, pp. 33–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Schaapveld, E. G. E. De Vries, W. T. A. Van Der Graaf, R. Otter, J. De Vries, and P. H. B. Willemse, “The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association?” Annals of Surgical Oncology, vol. 13, no. 4, pp. 465–474, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Kuru, “Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma,” European Journal of Surgical Oncology, vol. 32, no. 10, pp. 1082–1088, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Kuru and M. Bozgul, “The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 5, pp. 1328–1334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. K. Axelsson, H. T. Mouridsen, M. Düring, and S. Møller, “Axillary staging during surgery for breast cancer,” British Journal of Surgery, vol. 94, no. 3, pp. 304–309, 2007. View at Publisher · View at Google Scholar
  12. T. Cil, J. Hauspy, H. Kahn et al., “Factors affecting axillary lymph node retrieval and assessment in breast cancer patients,” Annals of Surgical Oncology, vol. 15, no. 12, pp. 3361–3368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Voordeckers, V. Vinh-Hung, J. Van De Steene, J. Lamote, and G. Storme, “The lymph node ratio as prognostic factor in node-positive breast cancer,” Radiotherapy and Oncology, vol. 70, no. 3, pp. 225–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. L. J. Megale Costa, H. Prado Soares, H. Amaral Gaspar et al., “Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer,” American Journal of Clinical Oncology, vol. 27, no. 3, pp. 304–306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Yildirim and U. Berberoglu, “Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients,” World Journal of Surgery, vol. 31, no. 2, pp. 276–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Vinh-Hung, H. M. Verkooijen, G. Fioretta et al., “Lymph node ratio as an alternative to pN staging in node-positive breast cancer,” Journal of Clinical Oncology, vol. 27, no. 7, pp. 1062–1068, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. W. A. Woodward, V. Vinh-Hung, N. T. Ueno et al., “Prognostic value of nodal ratios in node-positive breast cancer,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2910–2916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Katz, T. A. Buchholz, H. Thames et al., “Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 50, no. 2, pp. 397–403, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Joslyn and B. R. Konety, “Effect of axillary lymphadenectomy on breast carcinoma survival,” Breast Cancer Research and Treatment, vol. 91, no. 1, pp. 11–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Tai, K. Joseph, E. Sadikov, S. Mahmood, F. Lien, and E. Yu, “Nodal ratios in node-positive breast cancer-long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 3, pp. 662–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. I. L. Atahan, F. Yildiz, G. Ozyigit et al., “Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer,” Acta Oncologica, vol. 47, no. 2, pp. 232–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Martinez-Ramos, J. Escrig-Sos, M. Alcalde-Sanchez, A. Torrella-Ramos, and J. L. Salvador-Sanchis, “Disease-free survival and prognostic significance of metastatic lymph node ratio in T1-T2 N positive breast cancer patients. A population registry-based study in a European Country,” World Journal of Surgery, vol. 33, no. 8, pp. 1659–1664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. H. A. Hatoum, F. R. Jamali, N. S. El-Saghir et al., “Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer,” Annals of Surgical Oncology, vol. 16, no. 12, pp. 3388–3395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. B. C. H. van der Wal, R. M. J. M. Butzelaar, S. van der Meij, and M. A. Boermeester, “Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer,” European Journal of Surgical Oncology, vol. 28, no. 5, pp. 481–489, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Nieto, P. J. Cagnoni, E. J. Shpall et al., “A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant,” Clinical Cancer Research, vol. 5, no. 11, pp. 3425–3431, 1999. View at Google Scholar · View at Scopus
  26. A. Schneeweiss, R. Goerner, M. Hensel et al., “Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapy,” Biology of Blood and Marrow Transplantation, vol. 7, no. 6, pp. 332–342, 2001. View at Google Scholar · View at Scopus
  27. B. Bolwell, S. Andresen, B. Pohlman et al., “Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer,” Bone Marrow Transplantation, vol. 27, no. 8, pp. 843–846, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Duraker, Z. C. Çaynak, and B. Bati, “Is there any prognostically different subgroup among patients with stage IIIC (anyTN3M0) breast carcinoma?” Annals of Surgical Oncology, vol. 15, no. 2, pp. 430–437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. P. T. Truong, E. Berthelet, J. Lee, H. A. Kader, and I. A. Olivotto, “The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes,” Cancer, vol. 103, no. 10, pp. 2006–2014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Yildirim and U. Berberoglu, “Local recurrence in breast carcinoma patients with T1-2 and 1-3 positive nodes: indications for radiotherapy,” European Journal of Surgical Oncology, vol. 33, no. 1, pp. 28–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. T. Truong, W. A. Woodward, H. D. Thames, J. Ragaz, I. A. Olivotto, and T. A. Buchholz, “The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from british columbia and the M. D. Anderson cancer center,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 1, pp. 59–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. D. N. Krag and R. M. Single, “Breast cancer survival according to number of nodes removed,” Annals of Surgical Oncology, vol. 10, no. 10, pp. 1152–1159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Wilking, L. E. Rutqvist, J. Carstensen, A. Mattsson, and L. Skoog, “Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes,” Acta Oncologica, vol. 31, no. 1, pp. 29–35, 1992. View at Google Scholar
  34. P. Karlsson, B. F. Cole, K. N. Price et al., “The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer,” Journal of Clinical Oncology, vol. 25, no. 15, pp. 2019–2026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Bembenek and P. M. Schlag, “Lymph-node dissection in breast cancer,” Langenbeck's Archives of Surgery, vol. 385, no. 4, pp. 236–245, 2000. View at Google Scholar · View at Scopus
  36. D. W. Petrik, D. R. McCready, C. A. Sawka, and V. Goel, “Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer,” Journal of Surgical Oncology, vol. 82, no. 2, pp. 84–90, 2003. View at Publisher · View at Google Scholar · View at Scopus